NCT07833046Not yet recruiting
Long-term Follow-up Study in Subjects With Multiple Myeloma Previously Treated With GC012F Injection
Long-term Follow-up Study to Evaluate Subjects With Multiple Myeloma Treated With GC012F Injection
Source: ClinicalTrials.gov · Last updated 22 Sept 2026
Brief summary (registry, in English)
This is an open-label, multicenter, observational study (non-interventional study) to evaluate the long-term safety, efficacy, and in vivo pharmacokinetic persistence of CAR-T cells in subjects treated with GC012F Injection
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 40 (estimated)
- First submitted
- 15 Sept 2026
- Start date
- 15 Oct 2026
- Primary completion date
- 21 Mar 2039
- Lead sponsor
- RenJi Hospital
- Diseases
- Multiple myeloma, Childhood cancers
- NCT number
- NCT07833046
What you commit to
- Study type: Observational
- Planned participants: 40
- From 15 Oct 2026 to the primary completion date, 21 Mar 2039
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with multiple myeloma who participated in the main study but withdrew early without receiving GC012F Injection;
Other
- Patients who refuse to undergo long-term follow-up after GC012F Injection treatment;
Who the study is looking for
- Patients with multiple myeloma who previously received GC012F Injection infusion in an investigator-initiated trial;
- Patients who have completed the safety and efficacy follow-up of the main study or withdrawn early;
- Patients who agree to sign the informed consent form and are willing and able to comply with the visits, laboratory tests, and other protocol requirements specified in the study visit schedule;
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Renji Hospital, Shanghai Jiaotong University School of Medicine Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.